SH3GLB2 and breast cancer: To determine the underlying molecular events of RRIG1 in the inhibition of breast cancer cell proliferation, migration and invasion, we performed semiquantitative RT-PCR and western blotting analysis to assess RRIG1 regulation of gene expression and the RhoA activation assay to detect the changed RhoA activity.